Acacia Pharma Group plc a commercial stage biopharmaceutical company focused on developing and commercializing novel products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or cancer chemotherapy, announces the successful completion of its post-approval requirement clinical trial investigating the effects of BARHEMSYS® (amisulpride injection) in individuals with severe renal impairment.

A study of an investigational gene therapy for sickle cell disease has found that a single dose restored blood cells to their normal shape and eliminated the most serious complication of the disease for at least three years in some patients.

An experimental HIV vaccine based on mRNA—the same platform technology used in two highly effective COVID-19 vaccines—shows promise in mice and non-human primates, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Their results, published in Nature Medicine, show that the novel vaccine was safe and prompted desired antibody and cellular immune responses against an HIV-like virus.

Pimpri Chinchwad is known by many nomenclatures worldwide. Widely famous as Industrial Township, it is also recognized as Detroit of the East with the presence of many national and multinational automobile companies. Blessed with rich cultural heritage and history, Pimpri Chinchwad is the birthplace of many freedom fighters like Chaphekar and Halbe.

Post : Pharmacist

Banaras Hindu University ranks among the first few in the country in the field of academic and research output. This university has two campuses, 3 institutes, 16 faculties, 140 departments, 4 advanced centers and 4 interdisciplinary schools. The University is making its mark at the national and international levels in a number of frontier areas of Science, Social Science, Technology, Medicine and Agriculture etc.

The recruitment is conducted to the following posts to the Individuals who are Local Candidates of Chittoor District to work on Contract basis in under National Urban Health Mission(NUHM) in Chittoor District initially for a period of one year only.

Post : Pharmacist

Applications in the prescribed proforma are invited from the eligible candidates for recruitment of posts noted in the annexure on contract basis Under National Health Mission Programme, SPSR Nellore District.

Post : Pharmacist

USP is proud to be an equal opportunity/affirmative action employer. Employment selection and related decisions are made without regard to sex, gender identity, race, age, disability, religion, national origin, color, veteran status or any other protected class. We are committed to working with and providing reasonable accommodation to individuals with disabilities.

Post : Associate Scientific Liaison

Institute of Good Manufacturing Practices India (IGMPI), is a premier educational and training Institute for the areas of Pharmaceutical, Food, Nutrition and Healthcare. The Institute is located at Qutab Institutional Area in New Delhi.

IGMPI invites online applications from eligible candidates for various faculty positions in the field of Pharmaceutical, Food and Healthcare. 

Panjab University has been Accredited with a CGPA of 3.35 on a four point scale at A Grade valid for a period of 5 years from 25/06/2015. 1st among Universities of India and 38th in Asia, Times Higher Education Asian University rankings 2015. Ranked number one University in India and in the bracket 276-300 internationally in the Times Higher Education World University Rankings, 2014-2015 powered by Thomson Reuters.

Post : Project Assistant

Kanyakumari District Sunniyakumari District Health Association - Applications are invited to work on the following vacancies in the National Tuberculosis Prevention Program on 11 month contract basis on package pay.

Post : District Pharmacist

Applications are invited through offline mode (Physical applications) from the eligible candidates for recruitment to the below mentioned posts on Contract / Outsourcing basis under the control of Director of Medical Education to work in Government Maternity Hospital, Tirupati, Chittoor district.

Post : Pharmacist Gr-II

Coral Laboratories Ltd. is one of the most fastest growing Pharmaceutical company for exports. We are fully equipped with required facilities to develop formulations that are bio-equivalent, safe & efficacious. Coral Laboratories Limited produces various pharmaceutical formulations at three different locations all over India.

Sunlovis Pharmaceuticals is a Fast Growing Pharmaceuticals Company with a Strong Focus on supply of good Quality yet Affordable Medicine in India and across the World and is a Trusted Name among the Healthcare Professionals.  Sunlovis Competitive Advantage Steps From the World Class Manufacturing Facilities. We have a sharp Focus on giving Value added Services to our customer cost effectively. We offer a Strong Product Portfolio Spanning in Beta-lactam Categories.

Accuprec Research Labs Pvt Ltd. is FDCA approved, NABL accredited and ISO 9001:2015 certified CRO. Head Quarter of the CRO is located at Ahmedabad and branch offices at Canada and USA. Accuprec provides all type of Pharmaceutical testing solutions to its domestic and MNC clients.

Intas is a leading, vertically integrated global pharmaceutical formulation development, manufacturing and marketing company headquartered in India. Intas success and incessant growth lies in clinical execution of successful and strategic moves made in the areas of manufacturing, R&D, Biotechnology and global operations over three decades.

BIO BULK MANUFACTURING
Cell Culture - Upstream / Downstream Microbial - Downstream

Dr. Bowen Li is an incoming Tenure-Stream Assistant Professor of Pharmaceutical Sciences at the University of Toronto (starting Jan 2022). He is currently a postdoctoral associate at MIT, working with Professor Robert Langer and Professor Daniel Anderson. His current research is focused on employing engineering approaches to enhance the performance of mRNA-based therapeutics and vaccines for combating cancer and infection diseases.

Post : Postdoctoral Fellow Position

Vifor Pharma announced that the first patient has been enrolled in a double-blind, randomized phase-IIa clinical trial evaluating the safety, efficacy and tolerability of vamifeport in adult patients with sickle cell disease. Vamifeport, developed by Vifor Pharma, is a novel oral ferroportin inhibitor investigated for treatment of diseases characterized by ineffective production of red blood cells and iron overload, including SCD and beta-thalassemia. It has been granted orphan drug designation from both the U.S.

Vifor Pharma and Angion Biomedica Corp announced results from the exploratory phase-II GUARD trial of Angion’s ANG-3777 in patients undergoing cardiac surgery involving cardiopulmonary bypass at risk for developing acute kidney injury (CSA-AKI). The trial did not meet its primary endpoint of percentage increase in serum creatinine based upon the area under the curve (AUC). However, Angion and Vifor Pharma continue to review the data, based on the signal demonstrated in the clinically-relevant MAKE90 secondary endpoint.